Share on StockTwits

Fluidigm (NASDAQ:FLDM) CEO Gajus Vincent Worthington sold 6,000 shares of the company’s stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $26.55, for a total value of $159,300.00. Following the completion of the sale, the chief executive officer now directly owns 1,352 shares of the company’s stock, valued at approximately $35,896. The sale was disclosed in a document filed with the SEC, which is available at this link.

A number of analysts have recently weighed in on FLDM shares. Analysts at Piper Jaffray reiterated an “overweight” rating on shares of Fluidigm in a research note on Tuesday, May 6th. They now have a $50.00 price target on the stock, down previously from $51.00. Separately, analysts at Maxim Group cut their price target on shares of Fluidigm from $65.00 to $52.00 in a research note on Tuesday, May 6th. They now have a “buy” rating on the stock. Finally, analysts at Leerink Swann cut their price target on shares of Fluidigm from $52.00 to $48.00 in a research note on Tuesday, May 6th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Fluidigm presently has an average rating of “Buy” and a consensus target price of $44.76.

Fluidigm (NASDAQ:FLDM) traded down 0.20% during mid-day trading on Wednesday, hitting $25.46. The stock had a trading volume of 357,769 shares. Fluidigm has a 52-week low of $15.72 and a 52-week high of $49.46. The stock has a 50-day moving average of $32.04 and a 200-day moving average of $38.23. The company’s market cap is $714.4 million.

Fluidigm (NASDAQ:FLDM) last released its earnings data on Monday, May 5th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.26. The company had revenue of $25.70 million for the quarter, compared to the consensus estimate of $22.91 million. The company’s revenue for the quarter was up 77.2% on a year-over-year basis. Analysts expect that Fluidigm will post $-1.71 EPS for the current fiscal year.

Fluidigm Corporation (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.